TobraDex ST, a topical antibiotic and corticosteroid combination, is available in a tobramycin/dexamethasone 0.3%/0.05% strength. For more information call (800) 757-9195 or visit www.alcon.com.

Tobradex ST is supplied as an ophthalmic suspension containing 3mg/mL of tobramycin and 0.5mg/mL of dexamethasone. For more information visit eyevance.com. Related News.

Twenty-eight patients received docetaxel weekly, and 28 patients received docetaxel every 3 weeks. Eighteen patients (64%) who received weekly docetaxel developed epiphora. Epiphora was mild in seven ...

The U.S. Food and Drug Administration has approved Alcon's new drug application for a new formulation of a fixed combination of tobramycin and dexamethasone for treating inflammatory ocular ...

Dexamethasone and Tobramycin Ophthalmic Suspension 0.3%/0.1% is the generic version of TobraDex®, which is indicated for steroid-responsive inflammatory ocular conditions for which a ...

Clinical Trials Experience: The most frequent adverse reactions to topical ocular tobramycin (TOBREX ®) are hypersensitivity and localized ocular toxicity, including eye pain, eyelids pruritus ...

Harrow, a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications for the following products:. Harrow announced its ...